Fundraising Fox
JStar Capital Investments
Venture capitalActively deployingAustin · Seed–Series C · 13 people tracked
Also known as JSTAR Capital · JSTAR FUND MANAGERS, LLC · JSTAR HORIZON GP II, LLC
Find your way into JStar Capital Investments
Sign up to see every warm intro you have to JStar Capital Investments
- Paths you didn't know you had: your email and LinkedIn already hold routes to the JStar Capital Investments team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
JSTAR Capital Investments backs pioneering med-tech and healthcare companies whose breakthrough technologies and treatments can redefine medicine. Every investment is patient-centered, prioritizing solutions that deliver measurable improvements in health outcomes and address pressing global healthcare challenges. Focus areas include technologies that safeguard patients during complex cardiovascular procedures and reduce stroke/embolic risk, platforms modernizing healthcare delivery through imaging, surgical navigation, monitoring and workflow optimization, advancements improving implant performance and musculoskeletal restoration across trauma, spine and joint reconstruction, and breakthrough therapeutics and biologic delivery systems. The firm emphasizes sustainable, enduring value for investors and the broader healthcare ecosystem.
Source: firm website, verified Oct 13, 2026.
Team · 13 people
from the firm's website
Evan Pritchard is a commercial sales executive with over 25 years of experience in medical technology, working with both Fortune 500 companies and pre-revenue start-ups. He co-founded venture capital and private equity firms focused on medical technology and healthcare devices intended to address unmet clinical needs, lower healthcare costs, and generate returns for investors.
Jared Leger is a healthcare executive and licensed registered nurse. He focuses on developing solutions to improve healthcare delivery and patient care, and has worked on growing healthcare enterprises.
Beau Barnes has a background in healthcare finance, operations, and entrepreneurship. He previously served as COO for a private health system and later advised healthcare startups on operational and financial strategy. At JSTAR he supports portfolio companies and investors through financial strategy and operational insight.
Dr. David Nelson is a board-certified anesthesiologist with more than 30 years in private practice in Austin, Texas. He works on turning medical challenges into technology solutions, holds multiple patents in medical device design, and has an inventor/entrepreneur background bringing early-stage technologies from concept to commercialization.
Jessica Jasso has more than 15 years of experience as an executive assistant and operations manager within the healthcare sector. She has worked alongside CEOs, medical directors, and executive teams across various healthcare settings, focusing on detailed operational execution.
Kevin Lewis is a third-generation family physician and healthcare investor. He completed an undergraduate degree in biology at the University of North Texas, earned his medical degree from the University of North Texas Health Science Center in Fort Worth, and completed a Family Medicine residency at The University of Texas Southwestern/Seton Family of Hospitals program in Austin. He applies his clinical background to identifying and evaluating healthcare investments at JSTAR.
Dr. Nguyen is board certified in Internal Medicine and Cardiovascular Medicine by the American Board of Internal Medicine, and in Nuclear Cardiology by the Certification Board of Nuclear Cardiology. He belongs to the Travis County Medical Society and the American College of Cardiology, and speaks English and Vietnamese.
What they invest in
from 7 of 7 portfolio companiesHealthtech ×7Medical Devices ×5Biotech ×4Digital Health ×3Hardware ×3SaaS ×2InsurTech ×1Wellness & Fitness ×1
HQs:United States×6
Investments · 7 tracked
founders shown can be your intro pathBy year:2026 · 22024 · 13 dated
Adhere+ is a Remote Therapeutic Monitoring (RTM) platform with an AARC framework that automates audit-ready documentation for regulatory compliance and provides physician-designed care protocols.
Digital HealthHealthtechSaaSWashington, US
Peter Pitts(Director)James Breidenstein(Executive Officer, Director)Dan Cohen(Executive Officer, Director)Scott Sigman MD(Director)John Stineman(Director)
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures.
HardwareHealthtechMedical DevicesArden Hills, US
Robert F. Wilson(Founder & Chief Executive Officer)inJohn Gainor(Co-founder & Chief Technology Officer)inScott Youngstrom(Chief Financial Officer)inGavin Philipps(Chief Commercial Officer)in
BoardMarc Riviere(Director)Luc Marengere(Director)
Co-investorsTVM CapitalTVM Capital Life Science
Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris.
BiotechHardwareHealthtechMedical DevicesTampa, US
Bradley Brown(Executive Officer)inCharles Tribie(EVP, Manufacturing)
BoardAlan J. Simonian(Director)William M. Merhi(Director)
Osteocentric develops orthopedic implant systems for bone fixation, including fasteners, plates, and surgical instruments that use UnifiMI mechanical integration technology.
BiotechHardwareHealthtechMedical DevicesAustin, US
Significo develops digital health products and custom technology solutions for insurers and large employers, as well as licensable SaaS offerings like a personalized health recommendation engine and apps for chronic condition management and employee wellness.
Digital HealthHealthtechInsurTechSaaSWellness & Fitness
Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
David Narrow(Executive Officer, Director)inDevin O'Brien-Coon(Co-Founder & Chairman)inJerry L. Prince(Co-Founder)inJohn Rappe(Executive Officer)inAlex Yevzlin(Executive Officer)
BoardRobert Hallenbeck(Director)
Co-investorsFusionGaingelsKeiretsu ForumMaryland TEDCORembrandt Venture PartnersRiptide Ventures+3 more
__Twitter.png)
Zetagen is a biotechnology company focused on bone-related disease, developing small-molecule therapeutics and approaches targeting bone tumor progression, stem cell activity to promote bone formation, and cancers such as Ewing's sarcoma.
BiotechHealthtechMedical DevicesSyracuse, US
Joe C Loy(Executive Officer, Director)Peter B. Finn(Executive Officer)Nikhil Thakur, MD(Executive Officer, Director)David Tischler(Executive Officer, Director)
BoardRichard Warburg(Director)Ashok Kaveeshwar(Director)
Portfolio news
latest coverage across their companiesZetagen · finsmes.com · Nov 26, 2025
Frequently asked questions
- How many investments has JStar Capital Investments made?
- JStar Capital Investments has 7 tracked investments, including 3 dated in the last 24 months.
- What stage does JStar Capital Investments invest at?
- JStar Capital Investments invests at the Seed, Series A, Series B, Series C stages.
- What sectors does JStar Capital Investments focus on?
- JStar Capital Investments focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is JStar Capital Investments located?
- JStar Capital Investments is headquartered in Austin, US.
- Who does JStar Capital Investments co-invest with?
- JStar Capital Investments most often shares deals with Fusion, Gaingels, Maryland TEDCO, among 10 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.